Transferrin and iron salts modulate differently tumor necrosis factor- α secretion by cultured human mononuclear cells

Nutrition Research

Volumn 19, Issue 5, 1999, Pages 651-661

  Muñoz, Carlos ^a   Ríos, Ernesto ^b   López, Marcelo ^a   Olivares, Manuel ^a   Schlesinger, Liana ^a   Núñez, Marco T ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Cytokines; Iron deficiency; Iron metabolism; Iron salt; TNF ; Transferrin

Indexed keywords

IRON SALT; LIPOPOLYSACCHARIDE; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; IMMUNOREGULATION; IRON DEFICIENCY; IRON METABOLISM; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0033136313     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(99)00030-5     Document Type: Article

References (43)

1. Seligman PA, Kovar J, Gelfand EW. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiology 1992,60:19-26.
2. Kucera R, Brown CL, Paulus H. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts. J Cell Physiol 1983;117:158-68.
3. Aisen P, Brown EB. The iron-binding function of transferrin in iron metabolism. Semin Hematol 1977;13:31-53.
4. Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev 1987;67:520-82.
5. Kaplan J, Jordan I, Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 1991;266:2997-3004.
6. De Silva DM, Askwith CC, Kaplan J. Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev 1996;76:31-47.
7. DeMaeyer E, Adiels-Tegman M. The prevalence of anemia in the world. Rapp Trimest Statis Sanit Mond 1985;38:302-16.
8. Hershko C, Peto TEA, Weatherall DJ. Iron and infection. Br Med J 1988;296:660-4.
9. Sherman AR. Zinc, copper and iron nutriture and immunity. J Nutr 1992;122:604-9.
10. Chandra RK, Saraya AK. Immpaired immunocompetence associated with iron deficiency. J Pediatr 1975;86:899-902.
11. Krantman HJ, Young SR, Ank BJ, et al. Immune function in pure iron deficiency. Am J Dis Child 1982;136:840-4.
12. Berger J, Schneider D, Dyck JL, et al. Iron deficiency, cell-mediated immunity and infection among 6-36 month old children living in rural Togo. Nutr Res 1992;12:39-49.
13. Kuvibidila S, Nauss KM, Baliga BS, et al. Impairment of blastogenic response of splenic lymphocytes from iron-deficient mice: In vivo repletion. Am J Clin Nutr 1983;37:15-25.
14. Chandra RK. Immune response in iron-deficient children. J Pediatr 1976;88:698-9.
15. Spear AT, Sherman AR. Iron deficiency alters DMBA-induced tumor burden and natural killer cell cytotoxicity in rats. J Nutr 1992;122:46-55.
16. Nishiya K, Horowitz DA. Contrasting effects of lactoferrin on human lymphocytes and monocyte natural killer activity and antibody dependent cell mediated cytotoxicity. J Immunol 1982;129:2519-23.
17. Kuvibidila S, Baliga BS, Murthy KK. Impaired protein kinase C activation as one of the possible mechanisms of reduced lymphocyte proliferation in iron deficiency in mice. Am J Clin Nutr 1991;54:944-50.
18. Thorson JA, Smith KM, Gomez F, et al. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG mabs against the transfesrrin receptor and the iron chelator deferoxamine. Cell Immunol 1991;134:126-37.
19. Omara FO, Blakley BR. The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse. Brit J Nutr 1994;72:899-909.
20. Helyar L, Sherman AR. Iron deficiency and interleukin 1 production by rat leukocytes Am J Clin Nutr 1987;46:346-52.
21. Galan P, Thibault H, Preziosi P, et al. Interleukin 2 production in iron-deficient children. Biol Trace Elem Res 1992;32:421-6.
22. Muñoz C, Olivares M, Schlesinger et al. Increased in vitro tumour necrosis factor-α production in iron deficiency anemia. Eur Cytokine Netw 1994;5:401-4.
23. Beutler BA, Cerami M. Cachectin: More than a tumor necrosis factor. New Engl J Med 1987;316:379-85.
24. Alvarez-Hernández X, Liceaga J, McKay IC, et al. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989;61:319-22.
25. Johnson RA, Waddelow TA, Caro J, et al. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 1989;74:130-8.
26. Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989;3:1637-43.
27. Tsuji Y, Miller LL, Miller SC, et al. Tumor necrosis factor-α and interleukin 1-α regulate transferrin receptor in human diploid fibroblasts. J Biol Chem 1991;266:7257-61.
28. Fischer DS, Price DC. A simple serum iron method using the new sensitive chromogen trypiridyl-striazine. Clin Chem 1964;10:21-30.
29. International Nutritional Anemia Consultative Group (INACG). Measurement of iron status. The Nutrition Foundation. Washington, DC, 1985: 1-49.
30. Tucker SB, Pierre RY, Jordon RE: Rapid identification of monocyte in a mixed mononuclear cell preparation. J Immunol Methods 1977; 14:267-9.
31. van der Meer JWM, Endres S, Lonnemann G, et al. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leuk Biol 1988;43:216-23.
32. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
33. USP NF18. The United States Pharmacopeia, The National Formulary. United States Pharmacopeial Convention, INC. (1995) Rand McNally, Tauton, MA, USA Pp 1696 (part 85).
34. Chitambar CR, Sax D. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells. Blood 1992;80:505-11.
35. Mayor S, Presley JF, Maxfield FR. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk fowl process. J Cell Biol 1993;121:1257-69.
36. Nuñez MT, Tapia V, Arredondo M. Intestinal epithelia (Caco-2) cells acquire iron through the basolateral endocytosis of transferrin. J Nutr 1996;126:2151-8.
37. Novogrodsky A, Suthanthiran M, Stenzel KH. Ferro-mitogens: Iron-containing compounds with lymphocyte-stimulatory properties. Cell Immunol 1991;133:295-305.
38. Scuderi P. Differential effects of copper and zinc on human peripheral blood monocytes cytokine secretion. Cell Immunol 1990;126:391-405.
39. Goossens V, Grooten J, De Vos K, Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 1995;92:8115-9.
40. Durum SK, Oppenheim JJ. Macrophage-derived mediators: Interleukin 1, tumor necrosis factor, interleukin 6, interferon, and related cytokines. Fundamental Immunology, 1989. Edited by W.E. Paul, Raven Press Ltd., New York pp. 639-61.
41. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
42. Beck FWJ, Prasad AS, Kaplan J, et al. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997;272:E-1002-7.
43. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997;158:420-5.